RACHEL ASHCRAFT: Open Payments
NPI 1154688059 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 32 payments from 10 companies in 2025. Trend: 2023 $470 · 2024 $479 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $271 |
| Biogen, Inc. | 9 | $144 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $39 |
| Organon LLC | 1 | $27 |
| MILLICENT US INC | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| PFIZER INC. | 1 | $18 |
| Exeltis, USA Inc. | 1 | $16 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
| Hologic Sales and Service, LLC | 1 | $14 |
Products named: Veozah, ZURZUVAE, NEXPLANON, INTRAROSA, Mirena, ABRYSVO, SLYND, ACCRUFER.
Industry payments across AR — which companies pay providers there.
